Scientists launch major study to unlock secrets of aging
NCT ID NCT02339012
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 7 times
Summary
The GESTALT study is recruiting 900 adults aged 20 and older to investigate biomarkers related to aging. Participants will undergo a range of tests every two years, including blood work, imaging, and physical exams. The goal is to better understand how genetic and epigenetic changes contribute to aging and frailty.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal key biological markers of aging, potentially guiding future treatments to improve health in older age.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to therapies, and results may take years to translate into practical benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAIL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institute of Aging, Clinical Research Unit
RECRUITINGBaltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults